Non-invasive Surgical Wound Closure Market

Non-invasive Surgical Wound Closure Market Outlook (2022 to 2032)

The global Non-Invasive Surgical Wound Closure Market is estimated to be valued at USD 2,192.3 billion in 2022. This market is expected to grow at a CAGR of 4.1% over the forecast period (2022 to 2032) to reach a market size of USD 3,404.6 billion by 2032. Earlier, during the historical period of 2017 to 2021, the market accounted CAGR of 3.2%.

The non-invasive surgical wound closure market is steadily expanding due to an increase in operations performed globally. The demand for aesthetic surgery is rising, and the trend away from invasive to non-invasive surgery choices is shifting as well, creating new opportunities for the use of non-invasive surgical wound closures that possibly will one day become successful enterprises.

In the accident and emergency department, where there is a high patient volume, non-invasive procedures save doctors time. As a result, non-invasive surgical wound closures are in demand from a variety of customers.

In the upcoming years, prospects such as a significant rise in the number of skin closure product approvals and technical improvements are anticipated to drive the market's expansion.

The market expansion is anticipated to be accelerated by a growing focus on minimally invasive surgical techniques. Also predicted to provide a beneficial environment for market expansion is the rising number of product approvals. Derma surgeons deal with a variety of wounds that need to be closed regularly. Therefore they require a technique that is both time and money effective.

Additionally, there are many different types of skin closure materials accessible due to the rise in cosmetic treatments.

The market for non-invasive surgical wound closure is anticipated to experience tremendous development as a result of the rising demand for aesthetic procedures and the shift from invasive to non-invasive surgical treatments. There is a demand for aesthetic appeal since society has become increasingly mindful of appearance.

In addition to this, as the incidence of chronic wounds like diabetic foot ulcers, venous leg ulcers, and pressure ulcers rises, these devices are becoming tremendously popular since they reduce the risk or hazard of excessive scarring and infection.

Demand for non-invasive surgical wound closure and closure devices is also rising as a result of efforts to cut back on hospital stays to lower surgical healthcare costs, as well as a growing preference for products that enhance therapeutic outcomes.

Report Attribute	Details
Non-invasive Surgical Wound Closure Market Historical Growth Rate (2017 to 2021)	3.2%
Non-invasive Surgical Wound Closure Market Value (2022)	USD 2,192.3 billion
Non-invasive Surgical Wound Closure Market Anticipated Forecast Value (2032)	USD 3,404.6 billion
Non-invasive Surgical Wound Closure Market Projected Growth Rate (2022 to 2032)	4.1%

For instance, the Independent Diabetes Trust in the UK stated in 2019 that around 115,000 people in the country get diabetic foot ulcers each year, and 278,000 people receive treatment for venous leg ulcers. The typical healing time for these ulcers is 200 days.

The yearly incidence of diabetic foot ulcers ranges from 9.1 to 26.1 million worldwide, according to data released by the National Centre for Biotechnology Information (NCBI).

Market players are attempting to develop fresher surgical methods and technology. Any wound treatment or incision surgery can aim for fast closure with the development of an attractive and useful scar.

Stitches were once the sole choice for closing wounds, but as the market became saturated, competitors began to create less invasive treatments like staples and adhesives like sticky tapes and glue.

Market is Developing Owing to an Upsurge in Cosmetic Treatments

Acute wounds, chronic wounds, and surgical wounds are just a few examples of physical health issues that have a negative effect on wound recovery.

Over the past ten years, there has been a considerable increase in the prevalence of acute, chronic, and surgical wounds, mostly as a result of the increasing elderly population worldwide, rising traumatic wounds, budding surgery rates, and escalating rates of obesity and diabetes.

The number of people having cosmetic surgery is rising. The minimally invasive method also spares doctors' time in the accident and emergency department, where there is a high patient volume.

Due to its many benefits, including shorter recovery times, decreased risk of infection, cheaper cost, instantaneous wound sealing, and a reduction in the risk of needle-related injuries, non-invasive wound closure is in great demand.

Government funding is increasing to upgrade the healthcare system. It is anticipated that there will be more hospitals and clinics over the projection period, which will result in a rise in the need for non-invasive surgical wound closure.

The benefits of these closure devices, such as their great efficiency in ensuring safety, shorter recovery times, and accuracy, are what primarily drive adequate demand from customers. Non-invasive surgical wound closure is in high demand due to rising accident and sports injury rates, and this demand is expected to continue during the projection period.

Expansion of the Market is Constrained by the High cost of Advanced Non-invasive Surgical Wound Closure Products

The high cost of advanced wound closure devices and therapies for chronic wounds may limit their use, especially in cost-concerned nations of the Asia Pacific region. Patients and doctors select affordable wound closure procedures in these nations.

Despite the abundance of bioengineered dressings in these locations, due to their affordability, traditional and basic wound closure techniques remain preferred by physicians and patients.

Prerequisite for Aesthetic Measures Drives North American Market Expansion

Considering the cost of healthcare, the growing demands for aesthetic surgery, and the greater amount of disposable income, North America holds the greatest revenue share for non-invasive surgical wound closure, which is close to 39.9%.

The non-invasive surgical wound closure market in North America significantly contributes to the expansion of the global market. This fact is demonstrated by the increase in revenue of this region's top non-invasive surgical wound closure manufacturers.

Additionally, the need for aesthetic procedures and high disposable income are fueling this region's industrial expansion.

Due to the increased attention that key market players are paying to enter this region's market, it is anticipated that this region will continue to hold sizable market shares during the projection period. This can be attributable to regionally strong established businesses with efficient distribution networks, as well as established reimbursement systems.

The USA is one of the world's biggest markets for wound closure technology. Customers' preference for painless treatments has been noticed to be in high demand in this area and is most likely to take the lead in manufacturing during the forecast period.

The healthcare industry will drive demand for non-invasive surgical closures devices in the US and Canada. It is projected that the suitable sales increase over the forecast period would result from the growing government investment in the construction of healthcare infrastructure.

Developing Responsiveness of Minimally Invasive Surgical Measures Fuels Market Spread out in Europe

Nearly 30% of the market is also accounted for by Europe.

This is attributable to a sizable patient pool suffering from lifestyle-associated diseases like diabetes and obesity, increasing government investment in enhancing healthcare infrastructure, growth in the demand for affordable and cutting-edge care in the region, growing awareness of minimally invasive surgical procedures, and growing propensity of physicians toward adoption of cutting-edge minimally invasive skin closure systems in post-surgical and wound care.

Start-ups are Proceeding for Exceptional Inventions to Attain a Competitive Edge

As the wound closure market is extensively fragmented and competitive, new market entrants are experimenting with modern and updated technologies to invent different products.

For instance, in February 2022, Evonik Venture Capital invested in CircumFix Solutions, a Tennessee-based start-up that created a novel high-performance polymer sternal closure device that effectively seals and stabilizes the sternum following surgery.

Market-fueling Developments are being Primed by Market Participants

In order to stay competitive with other businesses in the field, the businesses are planning innovation, product releases, and collaborations. The noninvasive surgical wound closure industry is growing as key market participants consolidate their markets.

To avoid delays in approvals, corporations make significant investments in compliance, research, and development. This is important for them to save on investments and achieve profitability.

Example:

• In February 2021, MaxioCel, a series of revolutionary wound care products from Axio Biosolutions, obtained CE certification from Europe.
• In August 2020, ARIA is a digital platform and application that Smith & Nephew Plc. (UK) established to coordinate patient care delivery with providers throughout the surgical and clinical experience.
• In February 2020, AmnioExcel Plus Placental Allograft Membrane, Integra LifeSciences Holdings Corporation's most recent product for wound closure, was introduced by the Swedish company to help soft tissue repair.
• In May 2019, Acelity Inc., a manufacturer of wound dressings and other treatments to control bleeding, was acquired by 3M Co. for USD 6.7 billion.
• In February 2017, the Signia stapling system, a surgical stapler for minimally invasive surgery, was introduced by Medtronic. Surgeons receive real-time input from the system, and real-time data are automatically responded to. During minimally invasive operations, the device's Adaptive Firing technology automatically recognizes tissue variations and modifies the pace of stapling. These product development methods are expected to broaden the company's customer base and boost its position in the market.

Key Players

• Advanced Medical Solutions Group Plc
• Ethicon Endo-Surgery, Inc
• Abbott Laboratories
• Baxter International Inc.
• Medtronic, Inc.
• CP Medical, Inc.
• Aesculap AG & Co.KG
• Smith & Nephew
• Surgical Specialties Corporation
• Derma Sciences, Inc.
• Teleflex Medical OEM
• Zipline Medical, Inc
• Medi-zip GmbH
• Takeda Pharmaceuticals International GmbH (Nycomed Pharma GmbH)
• BSN Medical
• 3M Corporation
• Pro-Motion Medical B.V.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 4.1% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2017 to 2021
Forecast Period	2022 to 2032
Quantitative Units	Revenue in USD Billion and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered	Product Type, Application, End-user, Region
Regions Covered	North America; Latin America; The Asia Pacific; Middle East and Africa; Europe
Key Countries Profiled	USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASIAN, GCC Countries, South Africa
Key Companies Profiled	Advanced Medical Solutions Group Plc; Ethicon Endo-Surgery; Inc; Abbott Laboratories; Baxter International Inc.; Medtronic; Inc.; CP Medical; Inc.; Aesculap AG & Co.KG; Smith & Nephew; Surgical Specialties Corporation; Derma Sciences; Inc.; Teleflex Medical OEM; Zipline Medical; Inc; Medi-zip GmbH; Takeda Pharmaceuticals International GmbH (Nycomed Pharma GmbH); BSN Medical; 3M Corporation; Pro-Motion Medical B.V
Customization	Available Upon Request

 

Non-invasive Surgical Wound Closure Market: Segmentation

On the basis of product type:

• Adhesive
• Natural
• Synthetic
• Adhesive barrier products
• Hemostats
• Mechanical
• Active
• Flowable
• Sealants
• Fibrin
• Surgical

On the basis of application:

• Orthopedics
• Cosmetics
• Obstetrics and Gynecology
• Others

On the basis of end-user:

• Hospital
• Clinics
• Dermatological Clinical
• Ambulatory Surgical Centers
• Emergency Service Centers

On the basis of region:

• North America
• Latin America
• Asia Pacific
• Middle East and Africa (MEA)
• Europe

Frequently Asked Questions

What is the Growth Outlook for the Non-invasive Surgical Wound Closure Market?

The global non-invasive surgical wound closure market is expected to progress at a CAGR of 4.1% (2022 to 2032).

Which Region is Anticipated to Embrace the Maximum Share in the Global Non-invasive Surgical Wound Closure Market?

North America is expected to hold the highest share (39.9%) in the global non-invasive surgical wound closure market.

What is the Future of the Non-invasive Surgical Wound Closure Market?

Global non-invasive surgical wound closure market is predicted to account for USD 3,404.6 million by 2032.